MIR941-5

Across TCGA pan-cancer cohorts, MIR941-5 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR941-5 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR941-5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR941-5 expression acts as an unfavorable survival marker.

KIRC, UVM, and MESO are the cancer types where MIR941-5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	II,III,IV	0.197	0.669	.001	102	view →
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	81	view →
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	72	view →
ESCA	DFS	Tertile	II,III,IV	0.127	0.832	.010	28	view →
READ	DFS	Tertile	II,III,IV	0.350	0.836	<.001	24	view →
KIRP	DFS	Tertile	All	0.676	0.873	.023	18	view →
TGCT	DFS	Tertile	All	0.172	0.801	.033	18	view →
LGG	DFS	Tertile	All	0.148	0.406	.009	15	view →
THCA	OS	Tertile	II,III,IV	0.323	0.913	.049	6	view →
HNSC	OS	Tertile	All	0.156	0.406	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR941-5–KIRC (DFS)

Open the KIRC breakdown →